566 related articles for article (PubMed ID: 25374100)
1. Effects of amyloid and small vessel disease on white matter network disruption.
Kim HJ; Im K; Kwon H; Lee JM; Ye BS; Kim YJ; Cho H; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW
J Alzheimers Dis; 2015; 44(3):963-75. PubMed ID: 25374100
[TBL] [Abstract][Full Text] [Related]
2. Clinical effect of white matter network disruption related to amyloid and small vessel disease.
Kim HJ; Im K; Kwon H; Lee JM; Kim C; Kim YJ; Jung NY; Cho H; Ye BS; Noh Y; Kim GH; Ko ED; Kim JS; Choe YS; Lee KH; Kim ST; Lee JH; Ewers M; Weiner MW; Na DL; Seo SW
Neurology; 2015 Jul; 85(1):63-70. PubMed ID: 26062629
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment.
Park JH; Seo SW; Kim C; Kim GH; Noh HJ; Kim ST; Kwak KC; Yoon U; Lee JM; Lee JW; Shin JS; Kim CH; Noh Y; Cho H; Kim HJ; Yoon CW; Oh SJ; Kim JS; Choe YS; Lee KH; Lee JH; Ewers M; Weiner MW; Werring DJ; Na DL
Ann Neurol; 2013 May; 73(5):584-93. PubMed ID: 23495089
[TBL] [Abstract][Full Text] [Related]
4. Total MRI Small Vessel Disease Burden Correlates with Cognitive Performance, Cortical Atrophy, and Network Measures in a Memory Clinic Population.
Banerjee G; Jang H; Kim HJ; Kim ST; Kim JS; Lee JH; Im K; Kwon H; Lee JM; Na DL; Seo SW; Werring DJ
J Alzheimers Dis; 2018; 63(4):1485-1497. PubMed ID: 29843234
[TBL] [Abstract][Full Text] [Related]
5. Effects of amyloid and vascular markers on cognitive decline in subcortical vascular dementia.
Ye BS; Seo SW; Kim JH; Kim GH; Cho H; Noh Y; Kim HJ; Yoon CW; Woo SY; Kim SH; Park HK; Kim ST; Choe YS; Lee KH; Kim JS; Oh SJ; Kim C; Weiner M; Lee JH; Na DL
Neurology; 2015 Nov; 85(19):1687-93. PubMed ID: 26468407
[TBL] [Abstract][Full Text] [Related]
6. Distinctive Resting State Network Disruptions Among Alzheimer's Disease, Subcortical Vascular Dementia, and Mixed Dementia Patients.
Kim HJ; Cha J; Lee JM; Shin JS; Jung NY; Kim YJ; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW
J Alzheimers Dis; 2016; 50(3):709-18. PubMed ID: 26757039
[TBL] [Abstract][Full Text] [Related]
7. Brain Amyloid PET Tracer Delivery is Related to White Matter Integrity in Patients with Mild Cognitive Impairment.
Brown EE; Rashidi-Ranjbar N; Caravaggio F; Gerretsen P; Pollock BG; Mulsant BH; Rajji TK; Fischer CE; Flint A; Mah L; Herrmann N; Bowie CR; Voineskos AN; Graff-Guerrero A;
J Neuroimaging; 2019 Nov; 29(6):721-729. PubMed ID: 31270885
[TBL] [Abstract][Full Text] [Related]
8. Structural network efficiency predicts cognitive decline in cerebral small vessel disease.
Boot EM; Mc van Leijsen E; Bergkamp MI; Kessels RPC; Norris DG; de Leeuw FE; Tuladhar AM
Neuroimage Clin; 2020; 27():102325. PubMed ID: 32622317
[TBL] [Abstract][Full Text] [Related]
9. Altered whole-brain white matter networks in preclinical Alzheimer's disease.
Fischer FU; Wolf D; Scheurich A; Fellgiebel A;
Neuroimage Clin; 2015; 8():660-6. PubMed ID: 26288751
[TBL] [Abstract][Full Text] [Related]
10. Effects of APOE ε4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment.
Kim HJ; Ye BS; Yoon CW; Cho H; Noh Y; Kim GH; Choi YS; Kim JH; Jeon S; Lee JM; Kim JS; Choe YS; Lee KH; Kim ST; Kim C; Kang DR; Ki CS; Lee JH; Werring DJ; Weiner MW; Na DL; Seo SW
Neurobiol Aging; 2013 Nov; 34(11):2482-7. PubMed ID: 23769398
[TBL] [Abstract][Full Text] [Related]
11. Vascular Effects on Depressive Symptoms in Cognitive Impairment.
Kim Y; Jang H; Kim SJ; Cho SH; Kim SE; Kim ST; Kim HJ; Moon SH; Ewers M; Im K; Kwon H; Na DL; Seo SW
J Alzheimers Dis; 2018; 65(2):597-605. PubMed ID: 30056427
[TBL] [Abstract][Full Text] [Related]
12. MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.
Banerjee G; Kim HJ; Fox Z; Jäger HR; Wilson D; Charidimou A; Na HK; Na DL; Seo SW; Werring DJ
Brain; 2017 Apr; 140(4):1107-1116. PubMed ID: 28335021
[TBL] [Abstract][Full Text] [Related]
13. Amyloid burden, cerebrovascular disease, brain atrophy, and cognition in cognitively impaired patients.
Ye BS; Seo SW; Kim GH; Noh Y; Cho H; Yoon CW; Kim HJ; Chin J; Jeon S; Lee JM; Seong JK; Kim JS; Lee JH; Choe YS; Lee KH; Sohn YH; Ewers M; Weiner M; Na DL
Alzheimers Dement; 2015 May; 11(5):494-503.e3. PubMed ID: 25048578
[TBL] [Abstract][Full Text] [Related]
14. Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy.
Reijmer YD; Fotiadis P; Martinez-Ramirez S; Salat DH; Schultz A; Shoamanesh A; Ayres AM; Vashkevich A; Rosas D; Schwab K; Leemans A; Biessels GJ; Rosand J; Johnson KA; Viswanathan A; Gurol ME; Greenberg SM
Brain; 2015 Jan; 138(Pt 1):179-88. PubMed ID: 25367025
[TBL] [Abstract][Full Text] [Related]
15. Relative impact of amyloid-β, lacunes, and downstream imaging markers on cognitive trajectories.
Kim HJ; Yang JJ; Kwon H; Kim C; Lee JM; Chun P; Kim YJ; Jung NY; Chin J; Kim S; Woo SY; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Weiner MW; Na DL; Seo SW
Brain; 2016 Sep; 139(Pt 9):2516-27. PubMed ID: 27329772
[TBL] [Abstract][Full Text] [Related]
16. Effects of cerebrovascular disease and amyloid beta burden on cognition in subjects with subcortical vascular cognitive impairment.
Park JH; Seo SW; Kim C; Kim SH; Kim GH; Kim ST; Jeon S; Lee JM; Oh SJ; Kim JS; Choe YS; Lee KH; Shin JS; Kim CH; Noh Y; Cho H; Yoon CW; Kim HJ; Ye BS; Ewers M; Weiner MW; Lee JH; Werring DJ; Na DL
Neurobiol Aging; 2014 Jan; 35(1):254-60. PubMed ID: 23932881
[TBL] [Abstract][Full Text] [Related]
17. White matter integrity in small vessel disease is related to cognition.
Tuladhar AM; van Norden AG; de Laat KF; Zwiers MP; van Dijk EJ; Norris DG; de Leeuw FE
Neuroimage Clin; 2015; 7():518-24. PubMed ID: 25737960
[TBL] [Abstract][Full Text] [Related]
18. Disruption of cerebral networks and cognitive impairment in Alzheimer disease.
Reijmer YD; Leemans A; Caeyenberghs K; Heringa SM; Koek HL; Biessels GJ;
Neurology; 2013 Apr; 80(15):1370-7. PubMed ID: 23486876
[TBL] [Abstract][Full Text] [Related]
19. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
[TBL] [Abstract][Full Text] [Related]
20. Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment.
Mito R; Raffelt D; Dhollander T; Vaughan DN; Tournier JD; Salvado O; Brodtmann A; Rowe CC; Villemagne VL; Connelly A
Brain; 2018 Mar; 141(3):888-902. PubMed ID: 29309541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
